Skip to main content

Efficacy of clinical evaluations for COVID-19 on the front line

To the Editor:

In the midst of the COVID-19 pandemic, there remains limited availability of Food and Drug Administration-approved tests for presence of the SARS-CoV-2 agent [1, 2]. Even as testing capacity expands, optimization of resource utilization in the healthcare setting remains a significant priority [3, 4]. Thus, the vast majority of front line work being done to evaluate for possible COVID-19 is highly dependent on the clinical assessment of a presenting patient’s signs and symptoms. The extent to which current clinical assessments are effective, in the era of rapidly evolving local and professional guidelines, is not entirely clear.

We conducted a retrospective review of patients assessed for possible COVID-19 illness at our urban medical center in Los Angeles, California. The institutional review board deemed the study exempt. We carefully reviewed all clinical records to ascertain the provider’s level of clinical suspicion for COVID-19 illness and compared these assessments with available results of SARS-CoV-2 testing, in addition to longitudinal data on clinical outcomes. We found that the vast majority of patients (96% of N = 25) clinically assessed to have a low probability of COVID-19 illness were subsequently confirmed to have either a negative SARS-CoV-2 test result or, in the absence of testing, clinical stability without any further concern for COVID-19 illness (Table 1). All clinical assessments were performed by a physician, with some (16%) conducted by a nurse practitioner or physician assistant in conjunction with physician supervision.

Table 1 Characteristics, testing status, and clinical outcomes for N = 25 patients

In the absence of widespread readily available access to SARS-CoV-2 testing, clinical assessment is and will remain the standard of care for initially determining probability of COVID-19 illness and, in turn, appropriateness for receiving testing—especially in areas where testing availability is limited. This case series from an urban medical center suggests that despite the rapidly evolving body of knowledge around COVID-19 illness and its variable presentations among affected patients, clinical provider assessment of high versus low probability of active infection can be relatively reliable. This case series further supports the hypothesis that a well-informed clinical assessment, with or without concurrent access to rapid point-of-care SARS-CoV-2 testing, could be leveraged to more efficiently triage patients [5]—even those with medical comorbidities whose chronic illness burden may appear to pose a diagnostic challenge at the outset. In effect, a clinical evaluation that does not rely on viral testing results may be very accurate and substantially aid in ongoing efforts to conserve and appropriately prioritize the use of medical resources. Use of sound clinical judgment can also facilitate consideration of alternative diagnostic explanations.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

References

  1. 1.

    U.S. Food & Drug Administration. Drug Shortages Response| COVID-19. https://www.fda.gov/drugs/coronavirus-covid-19-drugs/drug-shortages-response-covid-19. Accessed 18 April 2020.

  2. 2.

    Jamil S, Mark N, Carlos G, Dela Cruz CS, Gross J, Pasnick S. Diagnosis and management of COVID-19 disease. ATS public health information series. Am J Respr Crit Care. 2020;201:19–22.

    Article  CAS  Google Scholar 

  3. 3.

    Prachand V, Milner R, Angelos P. Medically necessary, time-sensitive procedures: scoring system to ethically and efficiently manage resource scarcity and provider risk during the COVID-19 pandemic. J Am Coll Surg. 2020;231(2):281. https://doi.org/10.1016/j.jamcollsurg.2020.04.011.

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Glauser W. Proposed protocol to keep COVID-19 out of hospitals. CMAJ. 2020;192(10):E264. https://doi.org/10.1503/cmaj.1095852.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. 5.

    McCullough LB. In response to COVID-19 pandemic physicians already know what to do. Am J Bioeth. 2020;20(7):9. https://doi.org/10.1080/15265161.2020.1754100.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported in part by Cedars Sinai Medical Center, the Erika J Glazer Family Foundation, and NIH/NCI grant U54-CA260591.

Author information

Affiliations

Authors

Contributions

LB conceived of the study concept and design, helped acquire the data from the emergency department and inpatient setting, performed the analysis and interpretation of the data, and drafted the manuscript. JE provided critical revision of the manuscript for important intellectual content and provided statistical expertise regarding the analysis. MA and MJ also critically revised the manuscript for important intellectual content. ST and BR helped acquire the data from the emergency department and inpatient setting and also critically revised the manuscript for important intellectual content. SC helped formulate the study concept and design, helped with analysis and interpretation of the data, provided statistical expertise, and critically revised the manuscript for important intellectual content. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Lili L. Barsky.

Ethics declarations

Ethics approval and consent to participate

The institutional review board deemed the study exempt.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Barsky, L.L., Ebinger, J.E., Alotaibi, M. et al. Efficacy of clinical evaluations for COVID-19 on the front line. Int J Emerg Med 13, 54 (2020). https://doi.org/10.1186/s12245-020-00313-w

Download citation

Keywords

  • Clinical assessment
  • Effectiveness
  • COVID-19